pyrroles has been researched along with Basilar Artery Insufficiency in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Feng, Y; Gao, P; Lu, Z; Wang, P; Wang, S; Zhang, G; Zhou, P | 1 |
| Chen, TY; Kuo, YL; Lin, WC; Tan, TY | 1 |
| Berger, BL; Beuter, MJ; Callahan, AS; Devlin, TG | 1 |
1 trial(s) available for pyrroles and Basilar Artery Insufficiency
| Article | Year |
|---|---|
Efficacy and safety of intensive statin therapy in Chinese patients with atherosclerotic intracranial arterial stenosis: a single-center, randomized, single-blind, parallel-group study with one-year follow-up.
Topics: Aged; Atorvastatin; China; Clinical Protocols; Constriction, Pathologic; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Male; Middle Aged; Middle Cerebral Artery; Pyrroles; Single-Blind Method; Stroke; Vertebrobasilar Insufficiency | 2014 |
2 other study(ies) available for pyrroles and Basilar Artery Insufficiency
| Article | Year |
|---|---|
Effect of lipid-lowering therapy on the progression of intracranial arterial stenosis.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Cerebral Arteries; Constriction, Pathologic; Disease Progression; Female; Heptanoic Acids; Humans; Hyperlipidemias; Infarction, Middle Cerebral Artery; Intracranial Arteriosclerosis; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrroles; Secondary Prevention; Sex Distribution; Stroke; Treatment Outcome; Vertebrobasilar Insufficiency | 2009 |
Possible short-term amelioration of basilar plaque by high-dose atorvastatin: use of reductase inhibitors for intracranial plaque stabilization.
Topics: Aged; Angioplasty, Balloon; Anticholesteremic Agents; Atorvastatin; Cerebral Angiography; Combined Modality Therapy; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Male; Neurologic Examination; Pyrroles; Vertebrobasilar Insufficiency | 2001 |